iShares Biotechnology ETF $IBB Stake Lowered by Perkins Coie Trust Co

Perkins Coie Trust Co cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,119 shares of the financial services provider’s stock after selling 1,493 shares during the quarter. Perkins Coie Trust Co owned approximately 0.05% of iShares Biotechnology ETF worth $2,672,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Moors & Cabot Inc. increased its position in iShares Biotechnology ETF by 2.0% in the 1st quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock worth $3,716,000 after purchasing an additional 558 shares during the last quarter. IFP Advisors Inc grew its stake in shares of iShares Biotechnology ETF by 23.9% in the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock valued at $2,539,000 after buying an additional 3,831 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new position in iShares Biotechnology ETF in the first quarter worth approximately $45,000. Kingswood Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 81.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock valued at $570,000 after acquiring an additional 2,031 shares in the last quarter. Finally, John G Ullman & Associates Inc. acquired a new stake in iShares Biotechnology ETF in the first quarter valued at approximately $230,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $143.63 on Friday. The firm has a 50 day moving average of $136.53 and a two-hundred day moving average of $129.31. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Tuesday, September 16th will be issued a $0.0828 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.